The largest database of trusted experimental protocols

4 protocols using ki 67 staining

1

Proliferation Capacity of hAMSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proliferation capacity of the indicated hAMSCs was detected by using the Cell Counting Kit-8 (CCK-8, Japan) and Ki-67 staining (BioLegend, USA)-based FCM assay. Briefly, hAMSCs were incubated with the CCK-8 reagents at 37 °C for 2 h. The absorbance at 450 nm was read by microplate reader (Thermo Fisher, USA).
+ Open protocol
+ Expand
2

Modulation of NK Cell and T Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Autologous NK cells labeled with CTDR were cultured alone or co-cultured with macrophages with the indicated treatments (2:1) in complete medium (RPMI-1640 supplemented with 10% FBS) and stimulated with 100 U/mL IL-2 and 50 U/mL IL-15 (Cat# 200-15; PeproTech) for 4 days. The proliferation rate was then evaluated by flow cytometry for Ki-67 staining (Cat# 350503; BioLegend). In some experiments, 5 μg/mL anti-human B7-H4 neutralizing Ab (eBioscience) or 5 μg/mL mouse IgG2b control (Cat# 400301; BioLegend) was added to the co-culture.
For the T cell proliferation assay, autologous CD8+ T cells were labeled with 0.5 μM CFSE (Cat# C34554; Thermo Fisher Scientific) for 15 min at room temperature and incubated with mature dendritic cells (DCs; 5:1) and the indicated labeled macrophages (2:1) in RPMI-1640 medium supplemented with 5 μg/mL IL-12, 25 mM HEPES, 4 mM L-glutamine, 25 μM 2-mercaptoethanol, and 10% FBS. Proliferation of CD8+ T cells was measured by CFSE staining and flow cytometry after 4 days. In some experiments, 5 μg/mL anti-human B7-H4 neutralizing Ab or 5 μg/mL mouse IgG2b control (Cat# 400301; BioLegend) was added to the co-culture.
+ Open protocol
+ Expand
3

Evaluating STAT3 Inhibition in CALR Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was measured with XTT assay according to the manufacturer’s protocol (Biological Industries, Beit Haemek, Israel). For the STAT3 inhibition assay, STAT3 Inhibitor S3I-201 (573102, Sigma-Aldrich, Macquarie, Australia) was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 25 mM as the stock solution. CALRDEL cells were exposed to various concentrations of S3I-201 for 48 h, and the IC50 concentration was determined by XTT assay. Based on the obtained information, cells were treated with S3I-201 at a concentration of 25 µM that did not affect the cellular viability in subsequent STAT3 inhibition assays.
To assess cellular proliferation, cells cultured for 24 h were harvested for Ki67-staining (BioLegend, San Diego, CA, USA) and subsequent flow cytometric analysis. The percentages of apoptotic cells were determined using a FACSCanto II flow cytometer (BD Biosciences, San Jose, CA, USA) after the cells were treated with a 7-AAD and APC-Annexin V Apoptosis Detection Kit (BD Biosciences). All experiments were performed in triplicate, and only representative data were shown.
+ Open protocol
+ Expand
4

Modulating NK Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Autologous NK cells labeled with CTDR were cultured alone or co-cultured with macrophages with indicated treatments (2:1) in complete media (RPMI 1640 medium supplemented with 10% FBS) and stimulated with 100U/ml IL-2 and 50U/mL PeproTech) for 4 days. Afterward, the proliferation rate was evaluated by flow cytometry for Ki-67 staining (Cat# 350503, Biolegend) . In some experiments, 5 mg/ml anti-human PD-L1 neutralizing antibody (Cat# 329709, Biolegend), 5 mg/ml mouse IgG2b control (Cat# 400301, Biolegend) or 4 mg/ml 1-Methyl-D-tryptophan (1-MT, Cat# 452483, Sigma) was added in the co-culture.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!